Literature DB >> 3435110

Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.

R Piccolomini1, L Cellini, N Allocati, A Di Girolamo, G Ravagnan.   

Abstract

We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3435110      PMCID： PMC175007          DOI： 10.1128/AAC.31.10.1644

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Emerging bacterial resistance to the newer cephalosporins.

Authors:  K J Towner
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

2.  Proteus penneri and urinary calculi formation.

Authors:  S Krajden; M Fuksa; W Lizewski; L Barton; A Lee
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

Review 3.  Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimens.

Authors:  J J Farmer; B R Davis; F W Hickman-Brenner; A McWhorter; G P Huntley-Carter; M A Asbury; C Riddle; H G Wathen-Grady; C Elias; G R Fanning
Journal:  J Clin Microbiol       Date:  1985-01       Impact factor: 5.948

4.  Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.

Authors:  E Collatz; L Gutmann; R Williamson; J F Acar
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

Review 5.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

6.  Comparative in vitro activity of semisynthetic penicillins against Proteeae.

Authors:  P M Hawkey; S J Pedler; A Turner
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

7.  Identification of Proteus penneri sp. nov., formerly known as Proteus vulgaris indole negative or as Proteus vulgaris biogroup 1.

Authors:  F W Hickman; A G Steigerwalt; J J Farmer; D J Brenner
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

8.  Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces.

Authors:  H E Müller
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

9.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

10.  Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191
View more
  2 in total

Review 1.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

2.  Analysis of antibiotic resistance determinants in Proteus penneri.

Authors:  S Lukomski; M Pytlos; L Serwecinska; Z Sidorczyk; A Jaworski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-06       Impact factor: 3.267
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.